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Пухлино-асоційовані макрофаги (ПАМ) M2-типу домінують у пухлинах і продукують сприятливі для їх росту молекули, 
стимулюючи ріст пухлини. Однак, зміна M2-типу на М1 може уповільнювати або припиняти цей ріст. Для реалізації на-
прямку модуляції М1/М2 при лікуванні карциноми/раку молочної залози (РМЗ) необхідна обґрунтована діагностика і пі-
дтвердження негативного прогнозу ПАМ. Метою роботи було оцінити відношення пухлино-асоційованих макрофагів до 
післяопераційного прогнозу/виживання пацієнток з карциномою/раком молочної залози (РМЗ). Матеріалом дослідження 
були інтраопераційні тканини пухлин та іпсилатеральних лімфовузлів при радикальному видалені молочних залоз. 
Патоморфологічне дослідження лімфовузлів проводилося для уточнення діагностики стосовно N0/1. Щільність 
інфільтрації ПАМ визначали за допомогою імуногістохімічного забарвлення (ІГХ) CD68 та CD163 на 30 зразках п’яти мо-
лекулярно-біологічних типів РМЗ (по три клінічних випадки кожного). ІГХ дослідження по визначенню ПАМ і М2-
подібних макрофагів проведено за допомогою стрептавідин-пероксидазного методу. Дослідження дозволило встанови-
ти, що кількісне представництво СD68+ та CD163+ Мф дуже різнилося від пацієнтки до пацієнтки, а також в межах 
зразку, що залежить зокрема від морфологічних особливостей РМЗ, охопленого біопсією. Щільність інфільтрації CD163+ 
макрофагами вогнища РМЗ негативно корелювала з післяопераційним виживанням, але не достовірно, проте це вкла-
дається у загальну концепцію про негативний прогноз інфільтрації М2-подібними макрофагами. Потрібна більша кіль-
кість досліджень для підтвердження негативного значення щільності інфільтрації ПАМ первинного вогнища РМЗ для 
післяопераційного прогнозу. Не виключена захисна роль повноцінних М1-подібних ПАМ вогнища первинного ураження 
при РМЗ на рівні персоналізованого підходу. Перспективною є розробка диференційної діагностики і підходу до 
лікування РМЗ з урахуванням рівнів його інфільтрації субпопуляціями ПАМ. 
Ключові слова: рак/карцинома молочної залози, пухлино-асоційовані макрофаги, молекулярно-біологічні типи 
РМЗ, післяопераційний прогноз виживання. 
Tumor-associated macrophages (TAM) of the M2-type dominate in tumors and produce molecules, favorable for their growth, 
stimulating tumor growth. However, changing the M2-type for M1 can slow down or arrest this growth. For realization of the 
M1 / M2 modulation direction in the treatment of carcinoma / breast cancer (BC), a substantiated diagnosis and confirmation 
of the TAM negative prognosis is necessary. Therefore, the aim of the study was to evaluate the relation of tumor associated 
macrophages to the postoperative prognosis / survival of patients with 5 molecular-biological types of breast carcinoma. Mate-
rials of the study were intraoperative tissues of tumors and ipsilateral lymph nodes in radically removed mammary glands. 
Pathomorphological study of lymph nodes was conducted to clarify the diagnosis in relation to N0/1.  The density of TAM infil-
tration was determined by immunohistochemical staining of CD68 and CD163 in 30 samples of five molecular biological types 
of breast cancer (three clinical cases of each type). Immunohistochemical (IHC) studies for the determination of TAM and M2-
like macrophages were conducted using streptavidin-peroxidase method. The quantitative representation of CD68 + and 
CD163 + Mph is very different from patient to patient and also within one sample, which depends, in particular, on the mor-
phological characteristics of breast cancer, studied by the biopsy. The density of infiltration by CD163 + macrophages of the BC 
focus negatively correlated with postoperative survival, which did not reach statistical significance, but is included in the gen-
eral concept of a negative prognosis of infiltration by M2-like macrophages. Further research is needed to confirm the negative 
significance of the ТАМ infiltration density in the BC primary focus for postoperative prognosis. Promising is the development of 
differential diagnosis and approach to the treatment of breast cancer, taking into account the levels of its infiltration by sub-
populations of TAM. 
Key words: cancer / carcinoma of the mammary gland, tumor associated macrophages, molecular-biological types of. 
breast cancer, postoperative survival prediction 
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Introduction 
Tumor-associated macrophages (TAM) of the M2-
type dominate in tumors and produce molecules, favor-
able for their growth, stimulating tumor growth. However, 
changing the M2-type for M1 can slow down or arrest this 
growth. Such an effect is mediated by the direct activity 
of M1 and their ability to stimulate Th1-type cytotoxic T 
cells and other effector cells [1]. For realization of the M1 
/ M2 modulation direction in the treatment of carcinoma / 
breast cancer (BC), a substantiated diagnosis and con-
firmation of the TAM negative prognosis is necessary. 
Therefore, the aim of the study was to evaluate the rela-
tion of tumor associated macrophages to the postopera-
tive prognosis / survival of patients with 5 molecular-
biological types of breast carcinoma. 
Materials and methods 
Tissue samples. Biopsy samples and clinical data 
were obtained from patients undergoing treatment at Pol-
tava Regional Clinical Dispensary. The study was ap-
proved by the Ethics Commission of UMSA. The average 
age of patients was 60 years, ranging from 30 to 79 
years. 
Materials of the study were intraoperative tissues of 
tumors and ipsilateral lymph nodes in radically removed 
mammary glands. Pathomorphological study of lymph 
nodes was conducted to clarify the diagnosis in relation 
to N0/1. Immunohistochemical (IHC) characteristics of 
the removed tumors (HER2, ER, PR, Ki67) were used to 
determine the molecular-biological subtype of BC in order 
to balance the study groups. IHC and pathologic findings 
were obtained at the diagnostic and advisory center CSD 
Health care, Kyiv). 
Immunohistochemistry and antibodies. For IHC detec-
tion of TAM that infiltrated the primary focus of BC, we 
used the CD68 marker; to determine the M2-like TAM – 
the CD163 marker [2]. 
IHC studies for the determination of TAM and M2-like 
macrophages were conducted using streptavidin-
peroxidase method. Paraffin sections, 2-3 μm thick, ob-
tained by standard technique of the automated cycle of 
the pathologic-anatomical laboratory, were deparaffined, 
dehydrated, antigens were restored in citrate buffer (pH 
6.0) in a microwave oven (at a power of ≈600 W, 3 cycles 
of 7 minutes with a break for 1 min), cooled for 20 min, 
washed in disodium and phosphate buffered saline (PBS, 
pH 7.2-7.4) for 2 min, blocked endogenous peroxidase 
with a reagent from the PolyVue HRP / DAB Detection 
System (For Mouse & Rabbit Primary Antibodies, Diag-
nostic BioSystems, USA), washed in PBS for 3 min. The 
slices were then incubated at 4˚C overnight with mouse 
anti-CD68 monoclonal antibodies (clone PG-M1, REF PD 
M065-S, Diagnostic BioSystems, USA) and anti-CD163 
(clone 10D6, REF Mob460-01, in dilution 1: 100 in Anti-
body Diluent Buffer for DTP, Antibody Diluent, Dako, 
USA). Further, the sections were treated in two steps with 
the Mouse / Rabbit PolyVueTM HRP / DAB Detection 
System (Diagnostic BioSystems, USA), a detector sys-
tem for visualizing the chromosomal DAB response, the 
nuclei were bleached with hematoxylin Meyer and en-
closed with a cedar balm under the cover glass. Antibody 
Diluent buffer was used instead of the primary antibodies 
as the negative control, the lymph nodes tissues – as the 
positive one. 
Assessment of immunohistochemical staining. We 
conducted assessment by counting CD68+ TAM and 
CD163+ M2-like TAM under the light microscope (Biolam, 
LOMO, Russia: lens×40, eyepiece K7×, magnification 
×280, field diameter of the field of view 18 mm) in 7-10 
consecutive fields of view for the IHC-reaction of each 
section, calculating the arithmetic mean, within the tumor 
nests and tumor stroma. The count included im-
munopositive cells with macrophage morphology. Micro-
photographs were obtained using a Microscope Leica 
DM500, Leica, Germany, lens × 40). 
4-year follow-up. Patients were regularly observed 
during visits to the clinic or over the telephone for up to 4 
years (or more precisely, up to 58 months maximum), or 
until the time of death. Overall survival was used for 
prognostic analysis. 
Statistical analysis. All calculations were conducted 
using GraphPad Prism 5. The proportions were com-
pared using the χ2 test or Fischer's exact criterion. Over-
all survival was estimated using the Kaplan-Mayer 
method. The values of p≤0.05 were considered as statis-
tically significant for all analyzes. 
Results 
The study included 6 patients with 5 immunohisto-
chemical types of BC, equal in terms of metastases in the 
ipsilateral axillary lymph nodes, namely: 6 persons with 
non-luminal HER2+, 3 N0 and N1; 6 persons with luminal 
A, 3 N0 and N1, 6 persons with luminal B HER2-, 3 N0 
and N1; 6 persons with luminal B HER2+, 3 N0 and N1; 
and 6 persons with triple negative BC, also 3 N0 and N1, 
30 patients in total. 
The primary results of the calculation of immunoposi-
tive Mph are given in Table 1. 
Table 1 
Quantitative characteristics of tumor-associated macrophages, 
which infiltrate the primary focus of BC in each patient  
(average number in the field of view mg.×280) 
N0 N1 
IHC BC type  
CD68+ TAM CD163
+М2- 
like TAM CD68
+ TAM 
10.7 3.1 21.6 
3.6 1.9 32.1 
Non-luminal  
 HER2+ 
5.8 4.8 16.2 
16.5 7.4 9.2 
8.8 4.3 23.1 Luminal А 
14.1 4.9 8 
5.5 1 6.7 
16.6 1 4.3 Luminal B HER– 
19.6 1 8 
4.6 1 8.5 
6 1 2.5 Luminal B HER+ 
5.6 1 4.3 
12.5 5.1 23.5 
11.4 6.0 22.3 TNBC 
12.5 1.0 26.6 
 
In general, the quantitative characteristics of TAM 
showed that in all cases, the number of SD68+ Mph ex-
ceeded CD163+ Mph. All cells usually formed larger or 
smaller foci or clusters, which depended on the expressive-
ness of the stroma, the density of the tumor nests, the pres-
ence of necrosis centers and other morphological, very indi-
vidual characteristics of the samples (Fig. 1, 2) [3]. 
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Fig. 1. Dense infiltration of the CD68 + TAM sample i 
n triple negative BC N1. 
Fig. 2. Field of view with moderate density of infiltration of the 
CD163 + macrophages of luminal BC A N0. 
For statistic analysis of levels of TAM infiltration and 
postoperative survival, the participants of the study were 
divided into 2 subgroups, by conditionally high (≥15 cells 
in the field of view mg. × 280) and low (<15) infiltration 
density of the primary focus of BC CD68+ TAM. In the 
subgroup with a high level of infiltration, one person died, 
survival was 89%, in the subgroup with a low – two pa-
tients (83% survival), the difference was not reliable (Fig. 
3, p = 0.81, log-rank test). With comparable proportions 
of 1/10 and 2/20, cumulative mortality in the subgroups is 
the same. 
 
Fig. 3. Survival proportions and infiltration level of СD68 + TAM (Kaplan-Mayer Test). 
To find out the relationship between the density of in-
filtration of BC CD163+ M2-like TAM and patients sur-
vival, the conditional division into two subgroups was 
conducted as follows: a moderate level of infiltration:> 3 
cells in the field of view mg. × 280, the low level is 0-3. In 
a subgroup with a moderate level of infiltration, two per-
sons died (survival was 81%), in the subgroup with low – 
one patient (survival - 91%), which did not reach statisti-
cal significance, when compared (p = 0.94, log-rank test, 
Fig. 4) and needs further observations for the conclusion, 
but in principle coincides with the concept that relatively 
higher infiltration of the primary focus with M2-like Mph is 
negative [1]. 
 
Fig. 4. Proportions of survival, depending on the level of infiltration of CD163 + M2 (Kaplan-Mayer test) 
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When comparing proportions of cumulative mortality: 
2/18 (11%) (the subgroup with moderate infiltration den-
sity) versus 1/12 (8%) (the subgroup with low infiltration 
density), the differences also did not reach statistical sig-
nificance, p = 0.8. 
Discussion 
The study presents the results of analysis of possible 
correlations between the infiltration density of separately 
M1-like TAM, which are conventionally considered CD68+ 
Mph, and M2-like - according to the widely used marker 
CD163, the primary focus of breast cancer: the relatively 
higher infiltration level by precisely CD163+ macrophages 
correlated with a decrease in survival (81% ), which did 
not reach the reliability, however, is included in the gen-
eral concept of the negative prognosis of tumor infiltration 
precisely with M2-like Mph [1]. 
The study is organized as a cross-sectional, balanced 
by immunohistochemical characteristics of tumors 
(HER2, ER, PR, Ki67) (or the surrogate classification for 
molecular-biological subtypes), pilot, and a small number 
of participants is a limitation of this study. 
Previous studies have shown that increased macro-
phage density in biopsy samples of patients with breast 
cancer before treatment correlates with a decrease in 
non-recurrent and general survival [6]. The literature dis-
cusses the evidence that both M1 and M2 Mph have tu-
moral properties: in the early stages of transformation, 
M1-like TAM, due to the production of reactive oxygen 
and nitrogen forms, can potentially increase the rate of 
mutations in the epithelial cells and thus accelerate the 
tumor process; in the developed tumors, Mph demon-
strate alternatively activated M2 functions, including the 
production of immunosuppressive factors (IL-10 and 
TGF-β) which can actively suppress the anti-tumoral im-
mune response, produce growth factors and rebuild the 
matrix, supporting the growth of tumor cells and intensify-
ing the invasion [4]. Nevertheless, in a study devoted to 
the research of macrophages localization in the human 
breast tumors, the high representation of CD68+ Mph in 
the gaps of the ductal tumors correlated with a decrease 
in metastases in the lymph nodes [5], reflecting some re-
sistance to the tumor process. 
Other studies, with a larger number of participants 
(100), found that high levels of CD68+ TAM infiltration of 
the tumor tissue were reliably associated with a worse 
prognosis compared with a relatively low level of infiltra-
tion [6], but these results were not correlated with mo-
lecular biological varieties of breast cancer 
In its own study, we observed that both CD68+ and 
CD163+ Mph were grouped in different tumor sites and 
their localization was highly dependent on connective tis-
sue structures of the tumor. By the way, almost all sam-
ples of breast cancer, in particular luminal, were charac-
terized by a distinct desmoplastic response [3].  
Probably, TAM is an important regulator of the devel-
opment and remodeling of the intercellular matrix in the 
microenvironment of tumors, which has been studied 
less, but is a direct reflection of the standard functions of 
Mph [4,7]. This provision is indirectly confirmed by the 
data that the histological localization of TAM in different 
regions of breast cancer is correlated with the risks of 
metastasis and prognosis [8, 9]. 
According to earlier literature data, both M1 and M2 
TAM in BC can suppress the proliferation of T cells, 
showing immunosuppression and anti-tumor efficacy 
[10]. Other data indicate that not all TAMs have the ability 
to inhibit proliferation of CD8 T cells [11]. Consequently, 
some of the TAM functions are likely to be universal (re-
cruitment, localization, matrix remodeling), whereas other 
properties (specific interactions with other infiltration 
cells) may depend on the tumor model under study [4]. 
These findings may explain the findings of negative ef-
fects of various, but not all, TAM subpopulations on the 
prognosis of breast cancer, and therefore leave an as-
sumption about the protective role of some of them, in 
combination with individual tumor characteristics. 
In our study, the average quantitative indices of 
CD68+ and CD163+ Mph were lower than in other re-
searches, due to the count of immunopositive cells in 
successive tumor fields, and possibly due to the bal-
anced representation of 5 molecular genetic types of car-
cinoma. The mean values of the amounts of CD68+ and 
CD163+ Mph were very different from patient to patient 
and also within one sample. In other studies, the authors 
showed a higher number of CD68+ TAM in breast cancer: 
an average of 61.14 ± 23.76 cells in the field of view of 
the total of × 400, but the count of these cells was per-
formed in “intensive reaction areas” and patients were 
not balanced by the molecular- biological types of breast 
cancer [6]. 
The prospect for research is the development of dif-
ferential diagnosis and treatment of breast cancer, taking 
into account the levels of its infiltration by TAM subpopu-
lations. Regarding the direction of “repolarization” of Mph 
within the microenvironment of the tumor to the M1 phe-
notype, it is necessary to take into account their potential 
tumoral properties [4]. 
Conclusions 
1. The density of infiltration by CD163+ macrophages 
of the BC focus negatively correlated with postoperative 
survival, which did not reach statistical significance, but is 
included in the general concept of a negative prognosis 
of infiltration by M2-like macrophages. Further research is 
needed to confirm the negative significance of the ТАМ 
infiltration density in the BC primary focus for postopera-
tive prognosis. 
2. The protective role of full-rate M1-like TAM of the 
primary focus in breast cancer at the level of personal-
ized approach is not excluded. 
3. The quantitative representation of CD68+ and 
CD163+ Mph is very different from patient to patient and 
also within one sample, which depends, in particular, on 
the morphological characteristics of breast cancer, stud-
ied by the biopsy. 
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